+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Outsourcing Services Market - Global Forecast 2025-2030- Product Image
Pharmaceutical Outsourcing Services Market - Global Forecast 2025-2030- Product Image
Sale

Pharmaceutical Outsourcing Services Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6140099
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical outsourcing market is transforming rapidly as external partnerships become crucial drivers of efficiency, innovation, and compliance. Senior leaders face an increasingly complex landscape shaped by technology shifts, regulatory changes, and evolving global supply chain strategies.

Market Snapshot: Pharmaceutical Outsourcing Services

Pharmaceutical outsourcing services are embedded within a dynamic global ecosystem, responding to rising R&D costs, complex regulatory demands, and shrinking product timelines. The market is characterized by an intensified reliance on contract research, development, and manufacturing partners amid a demand for specialized external expertise and advanced technology integration. Notably, collaboration and knowledge exchange between sponsors and service providers have emerged as bedrocks of sustained competitive advantage.

Scope & Segmentation

  • Service Types: Analytical testing (bioanalytical, microbiological, physicochemical, stability), clinical trial management (Phase I-IV monitoring), manufacturing (API, biologics, finished dosage), R&D services (discovery, formulation, preclinical, process development), and regulatory consulting (compliance, pharmacovigilance, submissions).
  • Contract Models: Dedicated project teams (onsite, remote), fixed price structures (bundled, per-study), risk-sharing formats (milestone, revenue-based), and time & materials engagements (daily, hourly).
  • Development Phases: Spanning preclinical, Phase I, II, III, and IV activities for early discovery through post-market studies.
  • End Users: Academic and research institutes, large pharmaceutical companies, biotech firms, and generic drug manufacturers all demonstrate distinct preferences and needs across service categories.
  • Therapeutic Areas: Core focus includes cardiology, oncology, infectious diseases, and neurology, with segment-specific requirements for outsourced services.
  • Geographic Coverage: Regional dynamics span the Americas (U.S., Canada, Mexico, Brazil, Argentina), EMEA (including UK, Germany, France, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asia, and more).
  • Key Companies: Notable players such as Thermo Fisher Scientific Inc., Catalent, Lonza Group AG, WuXi AppTec, Samsung Biologics, Recipharm AB, Boehringer Ingelheim, Siegfried Holding AG, Cambrex, and Jubilant Pharmova drive sector innovation and diversification.

Key Takeaways for Market Leaders

  • Strategic outsourcing is pivotal, with decision-makers increasingly prioritizing partners who demonstrate deep domain knowledge, modern technology platforms, and adaptive quality management systems.
  • The incorporation of artificial intelligence, high-throughput screening, and continuous manufacturing via external providers enables organizations to access capability enhancements without major capital outlay.
  • Collaboration and co-investment in technology and process innovation are reshaping traditional operating models, with partnerships extending across drug development and manufacturing value chains.
  • Service differentiation, technological readiness, and robust compliance frameworks increasingly define market leadership and influence sponsor-provider selection criteria.
  • Capacity building in areas such as cell and gene therapies, advanced analytics, and regulatory affairs sets high entry barriers for new entrants while supporting long-term partner retention.

Tariff Impact: United States Tariffs 2025

The introduction of new U.S. tariffs in 2025 on APIs, intermediates, and packaging has sharpened focus on supply chain resilience and cost management. Many organizations have realigned sourcing strategies, investing in domestic and nearshore capabilities while diversifying supplier networks. These shifts have fueled demand for vertically integrated outsourcing partners and driven changes in contracting and risk-sharing approaches to safeguard project timelines and cost predictability.

Pharmaceutical Outsourcing Services Market: Methodology & Data Sources

Primary data collection consisted of in-depth interviews with senior executives, supplemented by targeted surveys among procurement decision-makers. Extensive secondary research encompassed regulatory publications, white papers, patent records, financial reports, proprietary databases, and peer-reviewed journals. All findings were validated with expert reviews and sensitivity analysis to ensure methodological rigor.

Why This Report Matters

  • Enables senior leaders to optimize outsourcing strategies against complex technological, regulatory, and tariff-driven headwinds.
  • Supports informed partner selection by mapping service, contract, regional, and end-user nuances across a maturing ecosystem.
  • Equips strategists with actionable intelligence to identify new revenue streams, anticipate market shifts, and accelerate time-to-market for breakthrough therapies.

Conclusion: Strategic Outlook

Pharmaceutical outsourcing continues to evolve as a cornerstone of innovation, operational efficiency, and competitive resilience. Organizations that invest in partnerships blending technology, expertise, and agility are best positioned to navigate the future pharmaceutical landscape.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increased demand for fully integrated end-to-end CDMO partnerships for process development and commercial manufacturing
5.2. Rapid growth in specialized biologics outsourcing to support scale-up of cell and gene therapy manufacturing
5.3. Rising adoption of continuous manufacturing technologies to enhance production efficiency and accelerate time to market
5.4. Strategic geographic diversification of clinical trial operations into emerging markets for cost reduction and faster patient enrollment
5.5. Expansion of regulatory consulting and inspection readiness services amid tightening global compliance and inspection standards
5.6. Digital transformation of pharmaceutical supply chain management through blockchain technology and AI-driven predictive analytics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pharmaceutical Outsourcing Services Market, by Service Type
8.1. Introduction
8.2. Analytical Testing
8.2.1. Bioanalytical Testing
8.2.2. Microbiological Testing
8.2.3. Physicochemical Testing
8.2.4. Stability Testing
8.3. Clinical Trial Management
8.3.1. Phase I Management
8.3.2. Phase Ii Management
8.3.3. Phase Iii Management
8.3.4. Phase Iv Monitoring
8.4. Manufacturing Services
8.4.1. Api Manufacturing
8.4.2. Biologics Manufacturing
8.4.3. Finished Dosage Manufacturing
8.5. R&D Services
8.5.1. Discovery Research
8.5.2. Formulation Development
8.5.3. Preclinical Testing
8.5.4. Process Development
8.6. Regulatory Consulting
8.6.1. Compliance & Quality Assurance
8.6.2. Drug Safety & Pharmacovigilance
8.6.3. Market Access Consulting
8.6.4. Regulatory Submissions
9. Pharmaceutical Outsourcing Services Market, by Contract Model
9.1. Introduction
9.2. Dedicated Project Team
9.2.1. Onsite Teams
9.2.2. Remote Teams
9.3. Fixed Price
9.3.1. Bundled Services
9.3.2. Per-Study Pricing
9.4. Risk-Sharing
9.4.1. Milestone-Based
9.4.2. Revenue Sharing
9.5. Time & Material
9.5.1. Daily Rate Engagement
9.5.2. Hourly Engagement
10. Pharmaceutical Outsourcing Services Market, by Development Phase
10.1. Introduction
10.2. Phase I
10.3. Phase II
10.4. Phase III
10.5. Phase IV
10.6. Preclinical
11. Pharmaceutical Outsourcing Services Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Big Pharma
11.4. Biotech
11.5. Generic Drug Manufacturers
12. Pharmaceutical Outsourcing Services Market, by Therapeutic Area
12.1. Introduction
12.2. Cardiology
12.3. Infectious Diseases
12.4. Neurology
12.5. Oncology
13. Americas Pharmaceutical Outsourcing Services Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Pharmaceutical Outsourcing Services Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Pharmaceutical Outsourcing Services Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Catalent, Inc.
16.3.3. Lonza Group AG
16.3.4. WuXi AppTec Co., Ltd.
16.3.5. Samsung Biologics Co., Ltd.
16.3.6. Recipharm AB
16.3.7. Boehringer Ingelheim International GmbH
16.3.8. Siegfried Holding AG
16.3.9. Cambrex Corporation
16.3.10. Jubilant Pharmova Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PHARMACEUTICAL OUTSOURCING SERVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PHARMACEUTICAL OUTSOURCING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PHARMACEUTICAL OUTSOURCING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PHARMACEUTICAL OUTSOURCING SERVICES MARKET: RESEARCHAI
FIGURE 26. PHARMACEUTICAL OUTSOURCING SERVICES MARKET: RESEARCHSTATISTICS
FIGURE 27. PHARMACEUTICAL OUTSOURCING SERVICES MARKET: RESEARCHCONTACTS
FIGURE 28. PHARMACEUTICAL OUTSOURCING SERVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHARMACEUTICAL OUTSOURCING SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHYSICOCHEMICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHYSICOCHEMICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY STABILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE I MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE I MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE II MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE II MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE III MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE III MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE IV MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE IV MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY API MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY API MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY BIOLOGICS MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY BIOLOGICS MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FINISHED DOSAGE MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FINISHED DOSAGE MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DISCOVERY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DISCOVERY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COMPLIANCE & QUALITY ASSURANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COMPLIANCE & QUALITY ASSURANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DRUG SAFETY & PHARMACOVIGILANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DRUG SAFETY & PHARMACOVIGILANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MARKET ACCESS CONSULTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MARKET ACCESS CONSULTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY SUBMISSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY SUBMISSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ONSITE TEAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ONSITE TEAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REMOTE TEAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REMOTE TEAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY BUNDLED SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY BUNDLED SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PER-STUDY PRICING, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PER-STUDY PRICING, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MILESTONE-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MILESTONE-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REVENUE SHARING, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REVENUE SHARING, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DAILY RATE ENGAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DAILY RATE ENGAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY HOURLY ENGAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY HOURLY ENGAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY BIG PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY GENERIC DRUG MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY GENERIC DRUG MANUFACTURERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 195. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 196. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 197. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 198. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 199. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 200. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 201. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 202. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 203. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, 2018-2024 (USD MILLION)
TABLE 204. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, 2025-2030 (USD MILLION)
TABLE 205. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, 2018-2024 (USD MILLION)
TABLE 206. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, 2025-2030 (USD MILLION)
TABLE 207. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 208. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 209. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, 2018-2024 (USD MILLION)
TABLE 210. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, 2025-2030 (USD MILLION)
TABLE 211. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, 2018-2024 (USD MILLION)
TABLE 212. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, 2025-2030 (USD MILLION)
TABLE 213. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, 2018-2024 (USD MILLION)
TABLE 214. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, 2025-2030 (USD MILLION)
TABLE 215. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, 2018-2024 (USD MILLION)
TABLE 216. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, 2025-2030 (USD MILLION)
TABLE 217. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 218. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 219. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 222. CANADA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 223. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 224. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 225. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 226. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 227. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 228. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 229. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 230. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 231. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, 2018-2024 (USD MILLION)
TABLE 232. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, 2025-2030 (USD MILLION)
TABLE 233. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, 2018-2024 (USD MILLION)
TABLE 234. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, 2025-2030 (USD MILLION)
TABLE 235. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 236. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 237. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, 2018-2024 (USD MILLION)
TABLE 238. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, 2025-2030 (USD MILLION)
TABLE 239. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, 2018-2024 (USD MILLION)
TABLE 240. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, 2025-2030 (USD MILLION)
TABLE 241. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, 2018-2024 (USD MILLION)
TABLE 242. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, 2025-2030 (USD MILLION)
TABLE 243. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, 2018-2024 (USD MILLION)
TABLE 244. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, 2025-2030 (USD MILLION)
TABLE 245. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 246. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 247. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 250. MEXICO PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY R&D SERVICES, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY REGULATORY CONSULTING, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEDICATED PROJECT TEAM, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY FIXED PRICE, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY RISK-SHARING, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY TIME & MATERIAL, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA PHARMACEUTICAL OUTSOURCING SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pharmaceutical Outsourcing Services market report include:
  • Thermo Fisher Scientific Inc.
  • Catalent, Inc.
  • Lonza Group AG
  • WuXi AppTec Co., Ltd.
  • Samsung Biologics Co., Ltd.
  • Recipharm AB
  • Boehringer Ingelheim International GmbH
  • Siegfried Holding AG
  • Cambrex Corporation
  • Jubilant Pharmova Limited

Related Reports

Biotechnology & Pharmaceutical Services Outsourcing Market - Global Forecast 2025-2030 - Product Image

Biotechnology & Pharmaceutical Services Outsourcing Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Pharmaceutical R&D Outsourcing Services Market - Global Forecast 2025-2030 - Product Image

Pharmaceutical R&D Outsourcing Services Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Stability Testing), End-use (Pharmaceutical Companies, Biopharmaceutical Companies), and Region with Growth Forecasts, 2025-2030 - Product Image

Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Stability Testing), End-use (Pharmaceutical Companies, Biopharmaceutical Companies), and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Personalized Medicine Outsourcing Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Application (Oncology, Rare Diseases), By Service, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Personalized Medicine Outsourcing Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Application (Oncology, Rare Diseases), By Service, By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Pharmaceutical Analytical Testing Outsourcing Market by Type, Service, End User, and Region 2025-2033 - Product Image

Pharmaceutical Analytical Testing Outsourcing Market by Type, Service, End User, and Region 2025-2033

  • Report
  • 134 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.